XENE
XENE
CA98420N1050
Xenon Pharmaceuticals Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.53B EUR
5.84B EUR
5.62B EUR
3.59B EUR
Enterprise Value
2.58B EUR
5.73B EUR
5.08B EUR
3.39B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.71x
--
--
--
Price to Sales
-
--
--
--
Price to Book
2.84x
4.7x
4.2x
6.16x
EV/Revenue
--
--
--
--
EV/EBITDA
-5.87x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-5.77%
-5.8%
-5.47%
-6.09%
ende